Skip to main content
Clinical Trials/NCT01192477
NCT01192477CompletedNot Applicable

Ozone Cardiovascular Effects in Genetically Susceptible People

University of Rochester1 site in 1 country80 target enrollmentStarted: May 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
80
Locations
1
Primary Endpoint
Nitric oxide bioavailability

Study Overview

Brief Summary

Increases in air pollution are associated with increases in deaths from cardiovascular disease, but the investigators know little about how ozone air pollution affects the cardiovascular system. The investigators proposed study will determine the effects of ozone on blood vessel and heart function that could worsen illness in people with underlying heart disease. This will be accomplished by studying healthy volunteers who inhale ozone in a controlled clinical study, and also by studying their exposure to ozone and other pollutants during their normal daily activities. The investigators will study volunteers who may be at increased risk for the effects of ozone because of genetic susceptibility. Understanding the effects of ozone on the heart and circulation can help establish appropriate air pollution standards, and provide strategies to protect the most susceptible people.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Never-smokers with normal spirometry based on the standards published by Morris and co-workers (Morris et al. 1971), and
  • •A normal electrocardiogram. -

Exclusion Criteria

  • •Any history of habitual smoking.
  • •Marijuana smoking within the past 5 years.
  • •Pregnancy.
  • •Any history of significant organ impairment, chronic respiratory disease, ischemic heart disease, active psychiatric disorder or current drug or alcohol abuse.
  • •Occupation involving regular, heavy dust or particle exposure, such as welding, mining, foundry work.
  • •FEV1 < 75% of predicted at baseline screening.
  • •Subjects with atopy or allergic rhinitis will not be excluded as long as they do not require regular treatment with antihistamines or systemic steroids.
  • •Subjects on certain prescription medications such as prednisone or statins will be excluded. Use of other medications will be considered on an individual basis. Subjects will not be asked to discontinue prescription medications for the purposes of this study.
  • •Hypertension (blood pressure higher than 140/90 mmHg or on antihypertensive medication).
  • •Subject lives outside the Rochester metropolitan area.

Arms & Interventions

Filtered air

Sham Comparator

Intervention: Ozone (Other)

Ozone 0.2 ppm

Experimental

Intervention: Ozone (Other)

Ozone 0.1 ppm

Experimental

Intervention: Ozone (Other)

Outcomes

Primary Outcomes

Nitric oxide bioavailability

Time Frame: Before and 3 hours after ozone exposure

We hypothesize that systemic vascular effects of exposure to ozone will be reflected in reductions in arterial blood nitrite or its A/V gradient. This will require simultaneous collection of venous and arterial blood.

Secondary Outcomes

  • Evidence of endothelial injury(Before and 3 hours after ozone exposure)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mark Frampton

Professor

University of Rochester

Study Sites (1)

Loading locations...

Similar Trials